Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module.
Yim N, Ryu SW, Choi K, Lee KR, Lee S, Choi H, Kim J, Shaker MR, Sun W, Park JH, Kim D, Heo WD, Choi C. · 2016
Read Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module. by Yim N, Ryu SW, Choi K, Lee KR, Lee S, Choi H, Kim J, Shaker MR, Sun W, Park JH, Kim D, Heo WD, Choi C. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4961865.txt.
Introduction
Nambin Yim and a large team of co-authors build engineered exosomes that ferry soluble proteins into target cells. Their study appeared in Nature Communications in 2016. Exosomes are tiny vesicles cells release, and they are promising delivery trucks for drugs. Loading them with working proteins, though, was hard. The team's system, named EXPLORs, uses a protein pair whose binding switches with blue light. Cargo proteins are pulled into forming exosomes while the light is on, then freed when it turns off.
Treated recipient cells, in dishes and in animals, took up the cargo and showed its function at much higher levels. The method needs no chemical linkers that might blunt the protein. The authors present EXPLORs as a general route for protein based therapy delivery. They note the light switch gives control over loading that passive methods lack.
Catalog record
| CREATOR | Yim N, Ryu SW, Choi K, Lee KR, Lee S, Choi H, Kim J, Shaker MR, Sun W, Park JH, Kim D, Heo WD, Choi C. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein–protein interaction module By Nambin Yim, Seung-Wook Ryu, Kyungsun Choi, Kwang Ryeol Lee, Seunghee Lee, Hojun Choi, Jeongjin Kim, Mohammed R. Shaker, Woong Sun, Ji-Ho Park, Daesoo Kim, Won Do Heo Published in: Nature Communications DOI: 10.1038/ncomms12277 ABSTRACT Nanoparticle-mediated delivery of functional macromolecules is a promising method for treating a variety of human diseases. Among nanoparticles, cell-derived exosomes have recently been highlighted as a new therapeutic strategy for the in vivo delivery of nucleotides and chemical drugs. Here we describe a new tool for intracellular delivery of target proteins, named ‘exosomes for protein loading via optically reversible protein–protein interactions' (EXPLORs). By integrating a reversible protein–protein interaction module controlled by blue light with the endogenous process of exosome biogenesis, we are able to successfully load cargo proteins into newly generated exosomes. Treatment with protein-loaded EXPLORs is shown to significantly increase intracellular levels of cargo proteins and their function in recipient cells in vitro and in vivo. These results clearly indicate the potential of EXPLORs as a mechanism for the efficient intracellular transfer of protein-based therapeutics into recipient cells and tissues. Despite the long list of therapeutic proteins available for treating various human diseases, the vast majority of clinically available protein-based drugs, such as cytokines, hormones and monoclonal antibodies, have been limited to extracellular mechanisms of action. Intracellular proteins have been identified for their potential as biopharmaceutical drugs; however, many of the challenges associated with intracellular protein delivery have yet to be solved1. Protein transduction methods have been proposed to deliver recombinant proteins into target cells in vitro and in vivo234. Although the techniques are promising, exposure of the protein surface in solution and the low refolding rate of recombinant proteins in target cells remain important obstacles for the intracellular delivery of therapeutic proteins5. Several lipid nanoparticle-mediated protein delivery methods have been postulated, as has protein encapsulation for protecting the proteins67. However, the absence of a separation mechanism between cargo proteins and lipid nanoparticles not only limits the efficiency of cytosolic delivery, preparation of these particles often involves complicated protein purification steps. To address these limitations, we developed an optogenetically engineered exosome system EXPLORs (exosomes for protein loading via optically reversible protein–protein interactions) that can deliver soluble proteins into the cytosol via controlled, reversible protein–protein interactions (PPIs). Exosomes are natural cell-derived extracellular vesicles that originate from internal endocytic compartments and multi-vesicular bodies and participate in intercellular communication8. Recent studies have sought to use exosomes as a new method for the in vivo delivery of siRNA or miRNA to specific target tissues by systemic injection91011. These methods were based on the passive loading of siRNAs or miRNAs into isolated exosomes by electrophoresis, a method poorly suited for loading of macromolecular proteins. Here we propose a novel protein-loading method in which cargo proteins can be actively loaded into exosomes through endogenous biogenesis processes, allowing for efficient delivery into the cytosol of target cells through controllable, reversible detachment from the exosomes. To achieve the controllable, reversible loading and delivery of target proteins into the exosome, we selected a photoreceptor cryptochrome 2 (CRY2), and CRY-interacting basic-helix-loop-helix 1 (CIB1) protein module, originally identified in Arabidopsis thaliana, which regulates floral initiation via blue light-dependent phosphorylation121314. We induced a transient docking of CRY2-conjugated cargo proteins to the exosomes by introducing CIBN (a truncated version of CIB1)14 conjugated with an exosome-associated tetraspanin protein CD9 and blue light illumination (Fig. 1a,b). Once the cargo proteins are introduced into the exosomes via the process of endogenous biogenesis, they can be detached from CD9-conjugated CIBN by removal of the illumination source, resulting in their release into the intraluminal space of the exosomes and enabling efficient delivery to the cytosolic compartment of target cells. RESULTS Light-inducible PPI module for producing EXPLORs We generated HEK293T cells that can produce EXPLORs loaded with mCherry (mCherry:EXPLOR) as a target protein by introducing vectors for two fusion proteins: CIBN-conjugated enhanced green fluorescent protein (EGFP)-tagged CD9 (CIBN-EGFP-CD9) and mCherry-tagged CRY2 (mCherry-CRY2). A single pulse irradiation of a 488-nm laser induced rapid movement of mCherry-CRY2 from the cytosolic compartment to the plasma membrane and intracellular compartments where the CIBN-EGFP-CD9 proteins were co-localized (Fig. 1c and Supplementary Fig. 1a). Similar results were obtained by the introduction of another photoreceptor module GIGANTEA, and LOV (light-, oxygen- and voltage-sensitive domain) proteins15 and other exosome-enriched tetraspanin proteins, such as CD63, CD81 and CD82 (Supplementary Fig. 1b,c). We could also observe light-induced co-localization of mCherry-CRY2 and CIBN-EGFP-CD9 by a cryo-immunogold electron microscopy analysis (Supplementary Fig. 2). Introduction of a mutant CRY2, mutated at an amino acid important in the photolyase function (D387A)16, abrogated such light-induced co-localization of CIBN-EGFP-CD9 and mCherry-CRY2 (Supplementary Fig. 3). On termination of light stimulation, the association between CIBN-EGFP-CD9 and mCherry-CRY2 dissociated gradually within 10 min, as described previously14 (Fig. 1d,e). Light-dependent loading of proteins in EXPLORs For production of mCherry:EXPLORs, we exposed transiently transfected HEK293T cells with continuous blue light illumination by installing a 460-nm light-emitting diode (LED; maximum power; 380 μW cm−2) in a CO2 incubator. After 48-h incubation with blue light illumination, EXPLORs were isolated from the supernatants by several different methods and confirmed for the hydrodynamic diameter by dynamic light scattering (Supplementary Fig. 4 and Supplementary Table 1). Immunoblotting results demonstrated that EXPLORs derived from optogenetically engineered HEK293T cells grown under blue light illumination contained significantly higher amounts of mCherry-CRY2 protein (84 kDa) than those obtained from cells grown in the dark (Fig. 2a and Supplementary Fig. 5). In particular, the highest efficiency in protein loading was seen in the power range from 20 to 50 μW cm−2 (Fig. 2b). The threshold power of the light-induced PPI was measured at ∼15 μW cm−2 by quantified laser stimulation (Supplementary Fig. 6) and at ∼20 μW cm−2 by the LED light (Supplementary Fig. 7). Continuous irradiation with blue light for up to 48 h did not induce significant cell death (Supplementary Fig. 8), and we further confirmed that EXPLORs did not contain detectable DNA fragments typical of apoptotic bodies (Supplementary Fig. 9a). Because genetically modified cells may release exosomes packed with not only the encoded protein but also genetic material (pDNA and mRNA) encoding this protein17, we further examined EXPLORs containing undetectable amounts of plasmid DNA (data not shown) and mCherry-CRY2 mRNA (Supplementary Fig. 9b). In addition, we tested the loading efficiency of mCherry proteins in EXPLORs in response to cycles of blue light illumination and darkness. Using a variety of cycle combinations, we identified a cycle consisting of 1 min of blue light illumination followed by 1 min of darkness as the optimal condition to produce mCherry:EXPLORs (Supplementary Fig. 10). We next examined the loading capacity of EXPLOR technology by producing firefly luciferase-containing EXPLORs. For the production of luciferase:EXPLOR, we cloned vectors for firefly luciferase-conjugated mCherry-CRY2 and confirmed light-induced PPI with CIBN-EGFP-CD9 by blue light stimulation with confocal microscopy (Supplementary Fig. 11). First, we compared luciferase:EXPLORs with a commercialized method for exosome protein loading, XPACK (System Biosciences, Mountain View, CA, USA), which is based on the principle that highly oligomeric, cytoplasmic proteins can be targeted to exosomes by plasma membrane anchors1819. We also included exosomes produced from cells transfected with the luciferase-conjugated mCherry-CRY2 vector, but not with